Biocept And Rosetta Genomics Collaborate To Evaluate microRNAs From Circulating Tumor Cells

By: via Benzinga
Biocept, Inc. (Nasdaq: BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.